PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brheartjLink to Publisher's site
 
Br Heart J. 1993 May; 69(5): 391–394.
PMCID: PMC1025099
Anticardiolipin antibodies in ischaemic heart disease: marker or myth?
K V Phadke, R A Phillips, D T Clarke, M Jones, P Naish, and P Carson
Department of Cardiology, North Staffordshire Hospital Centre, Stoke-on-Trent.
Abstract
OBJECTIVES--To assess the incidence and significance of anticardiolipin antibodies after myocardial infarction and in unstable angina. DESIGN--A prospective study of all patients under 60 admitted to the coronary care unit over a 12 month period with a diagnosis of acute myocardial infarction who were followed up for a further 12 months. Patients admitted with unstable angina were similarly assessed but not followed up. Anticardiolipin antibody concentrations were compared with those of age matched controls. SETTING--A district general hospital. PATIENTS--307 patients with acute myocardial infarction and 160 patients with unstable angina. RESULTS--Anticardiolipin antibody concentrations in the two patient groups did not differ significantly from those in the control groups. Antibody concentrations were not related to a history of angina or myocardial infarction nor were they related to subsequent cardiovascular complications. CONCLUSION--This study shows no significant association between anticardiolipin antibody concentrations and either myocardial infarction or unstable angina.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (633K), or click on a page image below to browse page by page.
Articles from British Heart Journal are provided here courtesy of
BMJ Group